SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
OMRON Corporation (OMRNY) trades at a trailing P/E of 0.4, forward P/E of 0.2. Trailing earnings yield is 270.27%, forward earnings yield 555.56%. PEG 0.01 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (0.4); PEG ≤ 1.0 — Peter Lynch undervalued (0.01); earnings yield beats bond yields (270.27%).
- Forward P/E 0.2 (down from trailing 0.4) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.01 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 270.27% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 555.56% as earnings recover.
Overall SharesGrow Score: 72/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — OMRNY
Valuation Multiples
P/E (TTM)0.4
Forward P/E0.2
PEG Ratio0.01
Forward PEG0.01
P/B Ratio0.00
P/S Ratio0.01
EV/EBITDA0.0
Per Share Data
EPS (TTM)$82.63
Forward EPS (Est.)$165.24
Book Value / Share$0.00
Revenue / Share$4,071.59
FCF / Share$0.00
Yields & Fair Value
Earnings Yield270.27%
Forward Earnings Yield555.56%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$218.95 |
$833.6B |
$47.29B |
5.7% |
| 2017 |
$215.09 |
$794.2B |
$45.99B |
5.8% |
| 2018 |
$296.85 |
$859.98B |
$63.16B |
7.3% |
| 2019 |
$260.78 |
$732.58B |
$54.32B |
7.4% |
| 2020 |
$114.34 |
$677.98B |
$23.45B |
3.5% |
| 2021 |
$214.72 |
$655.53B |
$43.31B |
6.6% |
| 2022 |
$305.65 |
$762.93B |
$61.4B |
8% |
| 2023 |
$372.19 |
$876.08B |
$73.86B |
8.4% |
| 2024 |
$41.22 |
$818.76B |
$8.11B |
1% |
| 2025 |
$82.63 |
$801.75B |
$16.27B |
2% |
